UnitedHealth (UNH) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $384.65B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Healthcare Plans |
| Country | US | CEO | Stephen J. Hemsley |
| IPO Date | 1984-10-17 | CAGR | 23.35% |
| Employees | 390,000 | Website | www.unitedhealthgroup.com |
| Div. Yield | 2.11% | Payout Ratio | 66% |
| Buy Back Yield | 0.43% | Total Yield | 2.54% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| Enterprise Value | $408.70B | P/E Ratio | 25.92 |
| Forward P/E | 18.88 | PEG Ratio | 0.52 |
| P/S Ratio | 0.85 | P/B Ratio | 3.7 |
| P/CF Ratio | 16.61 | P/FCF Ratio | 19.52 |
| EPS | $16.34 | EPS Growth 1Y | -32.62% |
| EPS Growth 3Y | -30.42% | EPS Growth 5Y | 2.71% |
| Revenue Growth 1Y | 6.46% | Gross Margin | 0.19% |
| Operating Margin | 0.04% | Profit Margin | 0.03% |
| ROE | 0.12% | ROA | 0.04% |
| ROCE | 0.09% | Current Ratio | 0.8 |
| Quick Ratio | 0.8 | Cash Ratio | 0.25 |
| Debt/Equity | 0.75 | Interest Coverage | 4.76 |
| Altman Z Score | 2.83 | Piotroski Score | 8 |
UnitedHealth (UNH) valuation & financials
UnitedHealth (UNH) has a market capitalization of $384.65B and trades at a price-to-earnings ratio of 25.9. It operates in the Healthcare sector (Medical - Healthcare Plans).
UnitedHealth's revenue grew +6.5% over the last year.
UnitedHealth's next earnings report is scheduled for October 27, 2026 before market open; analysts estimate EPS of $4.06.
UnitedHealth (UNH) — frequently asked questions
When does UnitedHealth (UNH) report earnings next?
UnitedHealth is expected to report earnings on October 27, 2026 before market open. Analysts estimate EPS of $4.06.
What is UnitedHealth's market cap?
UnitedHealth (UNH) has a market capitalization of $384.65B.
What is UNH's P/E ratio?
UnitedHealth trades at a price-to-earnings ratio of 25.9, with trailing twelve-month EPS of $16.34.
How fast is UnitedHealth growing?
UnitedHealth's revenue grew +6.5% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · Roche (ROG.SW) · Novartis (NVS)